Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.

Thrombosis research - 1 Jan 2008

Bereczky Zsuzsanna, Balogh Emilia, Katona Eva, Czuriga István, Kárpáti Levente, Shemirani Amir H, Edes István, Muszbek László

Abstract excerpt

INTRODUCTION: The effect of factor XIII A subunit (FXIII-A) Val34Leu polymorphism on the risk of coronary artery disease (CAD) has been extensively studied. In this study we investigated how FXIII-A Val34Leu genotypes influence plasma factor XIII levels in patients with coronary sclerosis (CS) and myocardial infarction (MI) and how fibrinogen level modulates this effect. PATIENTS AND METHODS: 955 consecutive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coronary Artery Disease
Share to Coronary Vessels

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor XIII

Share to Fibrinogen

Share to Homozygote

Share to Myocardial Infarction

Share to Protein Subunits

Share to Sclerosis

Source

Identifiers

PMID: 17597187
DOI: 10.1016/j.thromres.2007.05.012

Genes

CAD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.PMID 17597187Read ↗

Coagulation factor XIII-A Val34Leu polymorphism and the risk of coronary artery disease and myocardial infarction in a Chinese Han population.Semantic proximity Read ↗

Factor XIII val34leu and the risk of myocardial infarction.Semantic proximity Read ↗

Factor XIII A subunit Val34Leu polymorphism in patients suffering atherothrombotic ischemic stroke.Semantic proximity Read ↗

Factor XIII Val34Leu variant protects against coronary artery diseaseSemantic proximity Read ↗

The association between factor XIII Val34Leu polymorphism and early myocardial infarction.Semantic proximity Read ↗

Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis.Semantic proximity Read ↗

Aspirin alters the cardioprotective effects of the factor XIII Val34Leu polymorphism.Semantic proximity Read ↗

Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis.Semantic proximity Read ↗

Association of factor XIII Val34Leu polymorphism and coronary artery disease: A meta-analysis.Semantic proximity Read ↗

A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.Semantic proximity Read ↗

Effect of factor XIII-A Val34Leu polymorphism on myocardial infarction risk: a meta-analysis.Semantic proximity Read ↗

Role of factor XIII Val34Leu polymorphism in patients <45 years of age with acute myocardial infarction.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.